Ottesen M, Feldt-Rasmussen U F, Andersen J, Hippe E, Schouboe A
Medicinsk endokrinologisk afdeling F. Køebenhavns Amts Sygehus i Herlev.
Ugeskr Laeger. 1992 Dec 21;154(52):3758-62.
In a prospective study of thirty five consecutive patients with decreased plasma cobalamine (P-Cbl), twenty-two (63%) were diagnosed as having pernicious anaemia (PA) (no age or sex differences) on basis of the B12-absorption test and/or megaloblastic changes in the bone marrow. In this group ten patients were anaemic (six of whom were characterized as macrocytic), sixteen of nineteen examined had megaloblastic changes in the bone marrow, and all of thirteen examined had achlorhydria with positive correlation to Parietal Cell Antibodies (PCA). Two patients with PA had normal Cbl-absorption and two had malabsorption at the time of diagnosis. Twenty-one patients (95%) had PCA and thirteen (59%) were Intrinsic Factor Antibody (IFAb) positive. Three patients IFAb-seroconverted within a year. Among the remaining thirteen patients (37%), one had PCA but not IFAb and three were IFAb-positive all of whom had normal Cbl-absorption. Of the three patients with IFAb one had also PCA, one IFAb-seroconverted within three months, and one had microcytic anaemia with iron depleted bone marrow due to coecal cancer. Among twenty two healthy adult controls four (18%) had PCA while none had IFAb. This investigation shows that at the debut half of PA patients (55%) do not have anaemia, some have normal Cbl-absorption and some have malabsorption. 95% have PCA and 59% have IFAb. So, IFAb-negative PA is often seen (41%) and seroconversion can take place. Diagnosis is even more reliable, when achlorhydria is present in PCA-positive persons. Healthy PCA-positive persons are probably predisposed to develop PA. Patients with cbl-deficiency, IFAb and/or PCA must be considered as having latent PA even if they have normal haemoglobin and normal Cbl-absorption. These patients should be followed and, in case of anaemia or signs of neuropathia, treated.(ABSTRACT TRUNCATED AT 250 WORDS)
在一项对35例连续血浆钴胺素(P-Cbl)降低患者的前瞻性研究中,根据维生素B12吸收试验和/或骨髓巨幼细胞改变,22例(63%)被诊断为恶性贫血(PA)(无年龄或性别差异)。该组中10例患者贫血(其中6例为大细胞性贫血),19例接受检查的患者中有16例骨髓有巨幼细胞改变,13例接受检查的患者均有胃酸缺乏,且与壁细胞抗体(PCA)呈正相关。2例PA患者诊断时维生素B12吸收正常,2例存在吸收不良。21例患者(95%)有PCA,13例(59%)内因子抗体(IFAb)阳性。3例患者在1年内IFAb血清转化。其余13例患者(37%)中,1例有PCA但无IFAb,3例IFAb阳性,其维生素B12吸收均正常。3例IFAb阳性患者中,1例也有PCA,1例在3个月内IFAb血清转化,1例因盲肠癌导致小细胞性贫血伴骨髓铁缺乏。22例健康成人对照中,4例(18%)有PCA,无一例有IFAb。该研究表明,PA患者初发时半数(55%)无贫血,部分患者维生素B12吸收正常,部分存在吸收不良。95%有PCA,59%有IFAb。因此,常可见IFAb阴性的PA(41%),且可发生血清转化。当PCA阳性者存在胃酸缺乏时,诊断更可靠。健康的PCA阳性者可能易患PA。即使血红蛋白和维生素B12吸收正常,钴胺素缺乏、IFAb和/或PCA阳性的患者也必须被视为患有潜伏性PA。这些患者应进行随访,如有贫血或神经病变体征,则应进行治疗。(摘要截选至250字)